A phase I study of a prostaglandin D2 receptor antagonist for asthma/allergic disorders

Trial Profile

A phase I study of a prostaglandin D2 receptor antagonist for asthma/allergic disorders

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Jan 2012

At a glance

  • Drugs Prostaglandin D2 receptor antagonists
  • Indications Allergic asthma; Allergic rhinitis; Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top